JPRN-UMIN000011046尚未招募2 期
Phase II Trial of Carboplatin plus S-1 for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer complicated by Interstitial Pneumonia - Phase II Trial of CBDCA + S-1 for NSCLC with IP
Department of Respiratory medicine and Rheumatology, Tokushima University Hospital0 个研究点目标入组 33 人开始时间: 2013年6月26日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with pleural or pericardial effusion ,or ascites. 2) Patients with active double cancer. 3)Patients with significant complications. 4)Patients with serious diarrhea. 5)Patients with active infection. 6)Patients with symptomatic brain metastasis. 7)Being treated with flucytosine, phenytoin,warfarin. 8)Uncontrolled psychiatric disease. 9) allergic more than and equal to grade3. 10)History of serious allergic reaction with S-1 or CBDCA. 11)Patients with pregnancy or lactation. 12)Patients with HIV,HBV 13)Any patients judged by the investigator to be unfit to participate in the study
研究者
相似试验
招募中
2 期
A Phase II Study of Carboplatin and S-1 Followed by S-1 Maintenance for Patients Who Have Squamous Cell Lung CarcinomaSquamous Cell Lung CarcinomaJPRN-UMIN000007433Central Japan Lung Study Group (CJLSG)30
招募中
2 期
Phase I/II trial of carboplatin, TS-1, and concurrent radiation therapy in patients with unresectable locally advanced non-small cell lung cancernresectable locally advanced non-small cell lung cancerJPRN-UMIN000011663Dokkyo Medical University40
已完成
不适用
Phase I/II trial of carboplatin, TS-1, and concurrent radiation therapy in elderly patients with locally advanced non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000005794ational Cancer Center Hospital East40
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
已完成
1 期
Phase I/II trial of carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated radiotherapy for elderly patients with limited stage small cell lung cancer (TORG0604).limited stage small cell lung cancerJPRN-UMIN000007352Thoracic Oncology Research Group (TORG)41